Journals / Anatolian Current Medical Journal / 2026 / Volume: 8 Issue: 3

Parametrial resection in cervical cancer: optimizing oncological outcomes and complications

Ahmet Beyazıt(MUSTAFA KEMAL UNIVERSITY, TAYFUR ATA SÖKMEN FACULTY OF MEDICINE)0000-0001-5517-9624
Kenan Serdar Dolapçıoğlu(HATAY MUSTAFA KEMAL ÜNİVERSİTESİ, TAYFUR ATA SÖKMEN TIP FAKÜLTESİ)0000-0002-2296-9037
Mehmet Erdem(HATAY MUSTAFA KEMAL ÜNİVERSİTESİ, TAYFUR ATA SÖKMEN TIP FAKÜLTESİ)0000-0001-5671-1213
Pages
—
Publication Date
2026-05-22
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This supports a risk-adapted approach, underscoring the need for larger prospective studies.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aims: To evaluate the impact of the extent of parametrial resection on oncological outcomes and postoperative complications in early-stage cervical cancer patients undergoing type III radical hysterectomy.
📊
Key Findings & Data:Methods: A retrospective analysis was conducted on 38 patients treated between 2011 and 2022 with type III radical hysterectomy and pelvic/paraaortic lymphadenectomy.
💡
Conclusion & Impact:This supports a risk-adapted approach, underscoring the need for larger prospective studies.
🔬Design:Research Article
📍Scope:2011 Verileri
⚙️Variables:Radical hysterectomy · cervical cancer · parametrium resection

Abstract

Aims: To evaluate the impact of the extent of parametrial resection on oncological outcomes and postoperative complications in early-stage cervical cancer patients undergoing type III radical hysterectomy. Methods: A retrospective analysis was conducted on 38 patients treated between 2011 and 2022 with type III radical hysterectomy and pelvic/paraaortic lymphadenectomy. Parametrial length and volume were measured, and postoperative complications were assessed using Clavien-Dindo Grade III and IV criteria. Associations between parametrial resection extent, complications, blood transfusion, recurrence, and mortality were analyzed using univariate and multivariate logistic regression, adjusting for tumor stage. Results: Median follow-up was 32.0 months. Major complications occurred in 11 patients (28.9%): ureteral injury (n=6), bladder dysfunction (n=2), fascial dehiscence (n=2), and pelvic abscess (n=1). Greater parametrial length significantly correlated with these complications (p=0.007) and transfusion needs (p=0.023). Recurrence (26.3%) and mortality (21.1%) were independent of resection extent. Each 1 cm increase in parametrial length increased the odds of major complications (OR=2.953, 95% CI 1.245-7.004) and transfusion (OR=2.117 95% CI 1.072-4.181). Conclusion: These findings suggest that limiting the lateral extent of parametrial resection may reduce morbidity. Although our limited, retrospective cohort did not show a significant negative impact on recurrence or mortality, the statistical power is insufficient to definitively confirm oncological safety. This supports a risk-adapted approach, underscoring the need for larger prospective studies.

🔖

Cite This Article

Beyazıt, A., Dolapçıoğlu, K. S., Erdem, M. (2026). Parametrial resection in cervical cancer: optimizing oncological outcomes and complications. Anatolian Current Medical Journal, Volume: 8 Issue: 3. https://doi.org/10.38053/acmj.1880737

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (20)

  1. Sung H, H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-249. doi:10. 3322/caac.21660
  2. Hu Z, Ma D. The precision prevention and therapy of HPV-related cervical cancer: new concepts and clinical implications. Cancer Med. 2018;7(10):5217-5236. doi:10.1002/cam4.1501
  3. Cibula D, Raspollini MR, Planchamp F, et al. ESGO/ESTRO/ESP guidelines for the management of patients with cervical cancer-update 2023. Virchows Arch. 2023;482(6):935-966. doi:10.1007/s00428-023-03552-3
  4. Zreik TG, Chambers JT, Chambers SK. Parametrial involvement, regardless of nodal status: a poor prognostic factor for cervical cancer. Obstet Gynecol. 1996;87(5 Pt 1):741-746. doi:10.1016/0029-7844(96)00026-9
  5. Zeng C, Mi Y, Wang F, et al. Summary of evidence on prevention and management of bladder dysfunction in patients after radical hysterectomy. Nurs Open. 2024;11(7):e2240. doi:10.1002/nop2.2240
  6. Kasamatsu T, Arimoto T. Phase III clinical trials of radical hysterectomy with minimal parametrectomy for patients with early-stage cervical cancer: a review. Eur J Gynaecol Oncol. 2022;43(4):12. doi:10.22514/ejgo. 2022.026
  7. Wright JD, Grigsby PW, Brooks R, et al. Utility of parametrectomy for early stage cervical cancer treated with radical hysterectomy. Cancer. 2007;110(6):1281-1286. doi:10.1002/cncr.22899
  8. Schmeler KM, Frumovitz M, Ramirez PT. Conservative management of early stage cervical cancer: is there a role for less radical surgery? Gynecol Oncol. 2011;120(3):321-325. doi:10.1016/j.ygyno.2010.12.352
  9. Covens A, Rosen B, Murphy J, et al. How important is removal of the parametrium at surgery for carcinoma of the cervix? Gynecol Oncol. 2002;84(1):145-149. doi:10.1006/gyno.2001.6493
  10. Landoni F, Maneo A, Colombo A, et al. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet. 1997;350(9077):535-540. doi:10.1016/s0140-6736(97)02250-2
  11. Landoni F, Maneo A, Zapardiel I, Zanagnolo V, Mangioni C. Class I versus class III radical hysterectomy in stage IB1-IIA cervical cancer. A prospective randomized study. Eur J Surg Oncol. 2012;38(3):203-209. doi:10.1016/j.ejso.2011.12.017
  12. Plante M, Kwon JS, Ferguson S, et al. Simple versus radical hysterectomy in women with low-risk cervical cancer. N Engl J Med. 2024;390(9):819-829. doi:10.1056/NEJMoa2308900
  13. Reade CJ, Eiriksson LR, Covens A. Surgery for early stage cervical cancer: how radical should it be? Gynecol Oncol. 2013;131(1):222-230. doi:10.1016/j.ygyno.2013.07.078
  14. Wu J, Logue T, Kaplan SJ, et al. Less radical surgery for early-stage cervical cancer: a systematic review. Am J Obstet Gynecol. 2021;224(4):348-358.e5. doi:10.1016/j.ajog.2020.11.041
  15. Kinney WK, Hodge DO, Egorshin EV, Ballard DJ, Podratz KC. Identification of a low-risk subset of patients with stage IB invasive squamous cancer of the cervix possibly suited to less radical surgical treatment. Gynecol Oncol. 1995;57(1):3-6. doi:10.1006/gyno.1995.1091
  16. Baiocchi G, de Brot L, Faloppa CC, et al. Is parametrectomy always necessary in early-stage cervical cancer? Gynecol Oncol. 2017;146(1):16-19. doi:10.1016/j.ygyno.2017.03.514
  17. Birge O, Bakir MS, Dogan S, Tuncer HA, Simsek T. The Relationship between parametrial involvement and parametrial tissue removed in radical surgery in early-stage cervical cancer. World J Oncol. 2022;13(2): 59-68. doi:10.14740/wjon1439
  18. Tarney CM, Tian C, Randall LM, et al. Long-term survival in patients with low-risk cervical cancer after simple, modified, or radical hysterectomy. JAMA Network Open. 2025;8(5):e2510717-e2510717.
  19. Santía MC, Meschini T, Hsu HC, et al. Current updates on surgical management of patients with early-stage cervical cancer. Cancers (Basel). 2025;17(13):2259. doi:10.3390/cancers17132259
  20. Güler Çekiç S, Bulut M, Aldıkaçtıoğlu Talmaç M, et al. Risk factors for parametrial invasion in early-stage cervical cancer: toward less radical surgery. Turk J Obstet Gynecol. 2025;22(3):237-245. doi:10.4274/tjod.galenos.2025.39969